Psoriasis: What Is New in Markers of Disease Severity?

• 發表在: Medicina
• Main Authors: Mircea Tampa, Madalina Irina Mitran, Cristina Iulia Mitran, Clara Matei, Simona Roxana Georgescu
• 格式: Article
• 語言: 英语
• 出版: MDPI AG 2024-02-01
• 主題: psoriasis; severity; biomarkers
• 在線閱讀: https://www.mdpi.com/1648-9144/60/2/337

<i>Introduction</i>. Psoriasis is a chronic inflammatory skin disease and is the result of the interaction between numerous external and internal factors. Psoriasis presents a wide range of skin manifestations encompassing individual lesions varying from pinpoint to large plaques that can evolve into generalised forms. The lesions mirror the pathophysiological mechanisms involved in psoriasis pathogenesis, such as inflammation, dysregulation of immune response, uncontrolled proliferation of keratinocytes and angiogenesis. In this article, we present the latest advances achieved regarding markers that correlate with psoriasis severity. <i>Material and method</i>. We have performed a narrative review on markers of psoriasis severity, including articles published between March 2018–March 2023. <i>Results</i>. We have identified four categories of markers: inflammation markers, oxidative stress markers, hormonal markers and cancer-related markers. The main focus was on inflammation biomarkers, including immunomodulatory molecules, haematological parameters, inflammatory cells and costimulatory molecules. <i>Conclusions</i>. The analysed data indicate that markers associated with inflammation, oxidative stress and hormones, and cancer-related markers could be useful in assessing the severity of psoriasis. Nevertheless, additional research is required to ascertain the practical importance of these biomarkers in clinical settings.